Black Diamond Therapeutics (BDTX) Interest & Investment Income: 2019-2021
Historic Interest & Investment Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $588,000.
- Black Diamond Therapeutics' Interest & Investment Income fell 53.11% to $588,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $3.8 million, marking a year-over-year increase of 4.72%. This contributed to the annual value of $3.5 million for FY2021, which is 14.28% down from last year.
- According to the latest figures from Q4 2021, Black Diamond Therapeutics' Interest & Investment Income is $588,000, which was down 24.23% from $776,000 recorded in Q3 2021.
- Black Diamond Therapeutics' 5-year Interest & Investment Income high stood at $1.3 million for Q4 2020, and its period low was $1,000 during Q3 2019.
- Its 3-year average for Interest & Investment Income is $680,889, with a median of $744,000 in 2020.
- Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 116,100.00% in 2020, then tumbled by 53.11% in 2021.
- Quarterly analysis of 3 years shows Black Diamond Therapeutics' Interest & Investment Income stood at $440,000 in 2019, then soared by 185.00% to $1.3 million in 2020, then crashed by 53.11% to $588,000 in 2021.
- Its Interest & Investment Income was $588,000 in Q4 2021, compared to $776,000 in Q3 2021 and $1.2 million in Q2 2021.